McCauley, R., Zhang, A., Kota, V., Boccucci, J., Grunwald, M., Ulrickson, M., Hill, L., Muhsen, I., Sasine, J., Advani, A., Aldoss, I., Sandhu, K., Reshef, R., Luskin, M., Lin, C., Cassaday, R., Kopmar, N., Solh, M., Bobillo, S. O., Tsai, S., Hilal, T., Shah, B., Faramand, R., Park, J., Valtis, Y., Othman, T., Vasu, S., Bezerra, E., Leonard, J., Tan, V., O'Dwyer, K., Moore, J., Jamy, O., Mohty, R., Kumaran, M., Hoeg, R., Stock, W., Oliai, C., Lill, G., Schwartz, M., Koura, D., Dykes, K., Logan, A., Daunov, M., Byrd, K., Yalniz, F., Frey, N., Connor, M., Yaghmour, G., Gatell, V. I., Jackson, C., Oluwole, O., Al-Darobi, A., Chen, E., Lee, C., O'Connor, T., Dholaria, B., Bachanova, V., Tracy, S., Srinagesh, H., Miller, K., Sutherland, K., Majhail, N., Mountjoy, L., Malik, S., Ramakrishnan, A., Shaughnessy, P., Mathews, J., Wang, E., Battiwalla, M., Roloff, G., Muffly, L. (2025). CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel. Blood. https://doi.org/10.1182/blood-2025-2396